Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.50% | 3.87% | |||
| Total Other Revenue | -201.03% | -- | |||
| Total Revenue | 6.37% | 8.45% | |||
| Cost of Revenue | 10.43% | 8.28% | |||
| Gross Profit | -3.06% | 8.83% | |||
| SG&A Expenses | -2.29% | 4.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -175.35% | 444.79% | |||
| Total Operating Expenses | 5.20% | 9.93% | |||
| Operating Income | 16.83% | -3.24% | |||
| Income Before Tax | 163.52% | 109.46% | |||
| Income Tax Expenses | 12.01% | 38.18% | |||
| Earnings from Continuing Operations | 191.22% | 131.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -165.01% | -163.41% | |||
| Net Income | 195.43% | 32.44% | |||
| EBIT | 16.83% | -3.24% | |||
| EBITDA | 12.68% | -1.96% | |||
| EPS Basic | 183.15% | 38.70% | |||
| Normalized Basic EPS | -20.00% | 18.11% | |||
| EPS Diluted | 183.15% | 38.70% | |||
| Normalized Diluted EPS | -20.00% | 18.11% | |||
| Average Basic Shares Outstanding | 4.32% | -4.37% | |||
| Average Diluted Shares Outstanding | 4.32% | -4.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.90% | 5.86% | |||